2024 ICD-10-CM Diagnosis Code T37.8X2S
Poisoning by other specified systemic anti-infectives and antiparasitics, intentional self-harm, sequela
- ICD-10-CM Code:
- T37.8X2S
- ICD-10 Code for:
- Poisn by oth systemic anti-infect/parasit, slf-hrm, sequela
- Is Billable?
- Yes - Valid for Submission
- Chronic Condition Indicator: [1]
- Not chronic
- Code Navigator:
- Code Information
- Approximate Synonyms
- Clinical Classification
- Clinical Information
- Coding Guidelines
- Tabular List of Diseases and Injuries
- Diagnostic Related Groups Mapping
- Present on Admission (POA)
- Convert to ICD-9 Code
- Table of Drugs and Chemicals
- Patient Education
- Other Codes Used Similar Conditions
- Code History
T37.8X2S is a billable diagnosis code used to specify a medical diagnosis of poisoning by other specified systemic anti-infectives and antiparasitics, intentional self-harm, sequela. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.
T37.8X2S is a sequela code, includes a 7th character and should be used for complications that arise as a direct result of a condition like poisoning by other specified systemic anti-infectives and antiparasitics intentional self-harm. According to ICD-10-CM Guidelines a "sequela" code should be used for chronic or residual conditions that are complications of an initial acute disease, illness or injury. The most common sequela is pain. Usually, two diagnosis codes are needed when reporting sequela. The first code describes the nature of the sequela while the second code describes the sequela or late effect.
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Antimony compound overdose
- Antimony compound poisoning
- Flucytosine overdose
- Hydroxyquinoline overdose
- Hydroxyquinoline poisoning
- Hydroxyquinoline poisoning
- Intentional antimony compound overdose
- Intentional diiodohydroxyquinoline poisoning
- Intentional flucytosine overdose
- Intentional flucytosine poisoning
- Intentional hydroxyquinoline overdose
- Intentional hydroxyquinoline poisoning
- Intentional nitrofuran derivative overdose
- Intentional nitrofuran derivative poisoning
- Intentional sulfamethoxazole and/or trimethoprim overdose
- Intentional sulfamethoxazole and/or trimethoprim poisoning
- Intentional sulfamethoxazole and/or trimethoprim poisoning
- Intentional trimethoprim overdose
- Intentional trimethoprim poisoning
- Nitrofuran derivative overdose
- Poisoning by diiodohydroxyquin
- Poisoning by flucytosine
- Poisoning by flucytosine
- Poisoning by nitrofuran derivatives
- Poisoning by nitrofuran derivatives
- Sulfamethoxazole and/or trimethoprim overdose
- Toxic effect of antimony and/or antimony compound
- Trimethoprim overdose
- Trimethoprim poisoning
- Trimethoprim poisoning
Clinical Classification
Clinical Category | CCSR Category Code | Inpatient Default CCSR | Outpatient Default CCSR |
---|---|---|---|
Mental and substance use disorders; sequela | MBD034 | Y - Yes, default inpatient assignment for principal diagnosis or first-listed diagnosis. | Y - Yes, default outpatient assignment for principal diagnosis or first-listed diagnosis. |
Poisoning/toxic effect/adverse effects/underdosing, sequela | INJ075 | N - Not default inpatient assignment for principal diagnosis or first-listed diagnosis. | N - Not default outpatient assignment for principal diagnosis or first-listed diagnosis. |
Clinical Information
Bithionol
halogenated anti-infective agent that is used against trematode and cestode infestations.Cinoxacin
synthetic antimicrobial related to oxolinic acid and nalidixic acid and used in urinary tract infections.Clioquinol
a potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. the oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.Fluconazole
triazole antifungal agent that is used to treat oropharyngeal candidiasis and cryptococcal meningitis in aids.Flucytosine
a fluorinated cytosine analog that is used as an antifungal agent.Furazolidone
a nitrofuran derivative with antiprotozoal and antibacterial activity. furazolidone acts by gradual inhibition of monoamine oxidase. (from martindale, the extra pharmacopoeia, 30th ed, p514)Hexetidine
a bactericidal and fungicidal antiseptic. it is used as a 0.1% mouthwash for local infections and oral hygiene. (from martindale, the extra pharmacopoeia, 30th ed, p797)Hydroxychloroquine
a chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. it inhibits plasmodial heme polymerase. (from gilman et al., goodman and gilman's the pharmacological basis of therapeutics, 9th ed, p970)Iodoquinol
one of the halogenated 8-quinolinols widely used as an intestinal antiseptic, especially as an antiamebic agent. it is also used topically in other infections and may cause cns and eye damage. it is known by very many similar trade names world-wide.Itraconazole
a triazole antifungal agent that inhibits cytochrome p-450-dependent enzymes required for ergosterol synthesis.Diatrizoate Meglumine
a versatile contrast medium used for diagnostic x-ray radiology.Iothalamate Meglumine
a radiopaque medium used for urography, angiography, venography, and myelography. it is highly viscous and binds to plasma proteins.Ioxaglic Acid
a low-osmolar, ionic contrast medium used in various radiographic procedures.Meglumine
1-deoxy-1-(methylamino)-d-glucitol. a derivative of sorbitol in which the hydroxyl group in position 1 is replaced by a methylamino group. often used in conjunction with iodinated organic compounds as contrast medium.Meglumine Antimoniate
antimony salt of meglumine that is used in the treatment of leishmaniasis.Metronidazole
a nitroimidazole used to treat amebiasis; vaginitis; trichomonas infections; giardiasis; anaerobic bacteria; and treponemal infections.Nalidixic Acid
a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. it is an inhibitor of the a subunit of bacterial dna gyrase.Nifuratel
local antiprotozoal and antifungal agent that may also be given orally.Nitrofurantoin
a urinary anti-infective agent effective against most gram-positive and gram-negative organisms. although sulfonamides and antibiotics are usually the agents of choice for urinary tract infections, nitrofurantoin is widely used for prophylaxis and long-term suppression.Oxolinic Acid
synthetic antimicrobial related to nalidixic acid and used in urinary tract infections.Pefloxacin
a synthetic broad-spectrum fluoroquinolone antibacterial agent active against most gram-negative and gram-positive bacteria.Pipemidic Acid
antimicrobial against gram negative and some gram positive bacteria. it is protein bound and concentrated in bile and urine and used for gastrointestinal, biliary, and urinary infections.Piromidic Acid
antibacterial against mainly gram negative organisms. it is used for urinary tract and intestinal infections.Trimethoprim
a pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to pyrimethamine. it is potentiated by sulfonamides and the trimethoprim, sulfamethoxazole drug combination is the form most often used. it is sometimes used alone as an antimalarial. trimethoprim resistance has been reported.Trimethoprim Resistance
nonsusceptibility of bacteria to the action of trimethoprim.Trimethoprim, Sulfamethoxazole Drug Combination
a drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. it is effective in the treatment of many infections, including pneumocystis pneumonia in aids.
Coding Guidelines
When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined. If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.
The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of other systemic anti-infectives and antiparasitics (T37). Use the following options for the aplicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
Present on Admission (POA)
T37.8X2S is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.
CMS POA Indicator Options and Definitions
POA Indicator | Reason for Code | CMS will pay the CC/MCC DRG? |
---|---|---|
Y | Diagnosis was present at time of inpatient admission. | YES |
N | Diagnosis was not present at time of inpatient admission. | NO |
U | Documentation insufficient to determine if the condition was present at the time of inpatient admission. | NO |
W | Clinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission. | YES |
1 | Unreported/Not used - Exempt from POA reporting. | NO |
Convert T37.8X2S to ICD-9-CM
- ICD-9-CM Code: 909.0 - Late eff drug poisoning
Combination Flag - Multiple codes are needed to describe the source diagnosis code. Correct coding should be done based on contextual judgment. - ICD-9-CM Code: E959 - Late eff of self-injury
Combination Flag - Multiple codes are needed to describe the source diagnosis code. Correct coding should be done based on contextual judgment.
Table of Drugs and Chemicals
The parent code T37.8X2 of the current diagnosis code is referenced in the Table of Drugs and Chemicals, this table contains a classification of drugs, industrial solvents, corrosive gases, noxious plants, pesticides, and other toxic agents.
According to ICD-10-CM coding guidelines it is advised to do not code directly from the Table of Drugs and Chemicals, instead always refer back to the Tabular List when doing the initial coding. Each substance in the table is assigned a code according to the poisoning classification and external causes of adverse effects. It is important to use as many codes as necessary to specify all reported drugs, medicinal or chemical substances. If the same diagnosis code describes the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, utilize the code only once.
Patient Education
Poisoning
A poison is any substance that is harmful to your body. You might swallow it, inhale it, inject it, or absorb it through your skin. Any substance can be poisonous if too much is taken. Poisons can include:
- Prescription or over-the-counter medicines taken in doses that are too high
- Overdoses of illegal drugs
- Carbon monoxide from gas appliances
- Household products, such as laundry powder or furniture polish
- Pesticides
- Indoor or outdoor plants
- Metals such as lead and mercury
The effects of poisoning range from short-term illness to brain damage, coma, and death. To prevent poisoning it is important to use and store products exactly as their labels say. Keep dangerous products where children can't get to them. Treatment for poisoning depends on the type of poison. If you suspect someone has been poisoned, call your local poison control center at 1-800-222-1222 right away.
[Learn More in MedlinePlus]
Code History
- FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.
Footnotes
[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.